Skip to main content
. 2013 May 6;8(5):e62140. doi: 10.1371/journal.pone.0062140

Table 4. Factors associated with development of superimposed preeclampsia by univariate and multivariate* analysis at first prenatal visit.

Characteristics PE (n = 49) No PE (n = 162) p Multivariate analysis OR(95% CI) P
Pre-pregnancy BMI (Kg/m2, mean ± SD) n = 47 27.6±5.5 n = 155 28±6.8 .68
Booking gestational age (wk, mean ± SD) 18.3±5.5 18±5.6 .75
Maternal age (years) .35
<30 # (%) 7 (14.3) 15 (9.3)
30–35 # (%) 18 (36.7) 50 (30.9)
≥35 # (%) 24 (49) 97 (59.8)
Ethnicity .005
White # (%) 13 (26.5) 81 (50) 1 ref
Black # (%) 36 (73.5) 77 (47.5) 1.65 (0.73–3.72) .22
Other # (%) 0 4 (2.5)
Nulliparous # (%) 4 (8.1) 35 (21.6) .03 0.70 (0.20–2.37) .56
Previous preeclampsia # (%) 24/45 (53.3) 21/127 (16.5) <.0001 4.05 (1.61–10.16) .003
Previous FGR # (%) 14/45 (31.1) 24/127 (18.9) .03 0.99 (0.36–2.69) .98
Previous abruptio placenta # (%) 4/45 (8.9) 5/127 (3.9) .21
Tobacco use # (%) 2 (4.1) 18 (11.1) .82
Booking systolic blood pressure (mmHg) .005
<130 # (%) 11 (22.4) 76 (46.9)
130–140 # (%) 16 (32.7) 45 (27.8)
≥140 # (%) 22 (44.9) 41 (25.3)
Booking diastolic blood pressure (mmHg) .0004
<80 # (%) 14 (28.6) 94 (58)
80–90 # (%) 21 (42.8) 50 (30.9)
≥90 # (%) 14 (28.6) 18 (11.1)
Booking MAP≥95 mmHg # (%) 40 (81.6) 73 (45.1) <.0001 4.60 (1.94–10.93) .0006
Duration of hypertension ≥4 years # (%) 34 (69.4) 69/152 (45.4) .003 2.09 (0.95–4.60) .07
Antihypertensive at booking n = 48 n = 159 .86
One drug only # (%) 35 (72.9) 117 (73.6)
Two drugs # (%) 10 (20.8) 35 (22)
> two drugs # (%) 3 (6.3) 7 (4.4)
Aspirin use # (%) 15 (30.6) 34 (21) .16
*

logistic regression analysis performed for variables with a p<.1 at univariate analysis at booking; PE: superimposed preeclampsia.